MusclePharm Maintains NASDAQ Goal Despite SEC Investigation
This article was originally published in The Tan Sheet
Executive Summary
The sports nutrition supplement marketer’s latest earnings statement includes the sort of sales and loss figures that have grabbed SEC’s attention and made some investors leery of the firm’s shares, which currently are traded over-the-counter.